Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Torture exposure and the functional brain: investigating disruptions to intrinsic network connectivity using resting state fMRI.

Translational psychiatry·2022
Same author

Exploring interleukin-6, lipopolysaccharide-binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depression.

Acta neuropsychiatrica·2021
Same author

Preventing suicide by young people requires integrative strategies.

The Medical journal of Australia·2021
Same author

Questions in Psychiatry (QuiP): Using your Apple all day, might keep the doctor away?

Bipolar disorders·2021
Same author

Novel insights into irritability: the relationship between subjective experience, age and mood.

BJPsych open·2021
Same author

Default-mode and fronto-parietal network connectivity during rest distinguishes asymptomatic patients with bipolar disorder and major depressive disorder.

Translational psychiatry·2021

Related Experiment Video

Updated: Jul 19, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Emerging drugs for bipolar disorder.

Philip B Mitchell1, Gin S Malhi

  • 1School of Psychiatry, University of New South Wales, Black Dog Institute, Prince of Wales Hospital, Randwick, Sydney, NSW 2031, Australia. phil.mitchell@unsw.edu.au

Expert Opinion on Emerging Drugs
|October 27, 2006
PubMed
Summary

Bipolar disorder treatments have improved in safety but not efficacy, with lithium remaining the benchmark. Emerging medications include anticonvulsants and antipsychotics, but true advances await understanding of the disorder's molecular causes.

Related Experiment Videos

Last Updated: Jul 19, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Bipolar disorder is a common mental health condition causing mood swings.
  • It is associated with significant morbidity and mortality.
  • Current treatments offer limited efficacy improvements over lithium.

Purpose of the Study:

  • To review current and emerging pharmacotherapies for bipolar disorder.
  • To discuss future directions and challenges in bipolar disorder treatment.
  • To highlight the need for understanding underlying pathogenetic processes.

Main Methods:

  • Literature review of current and emerging medications for bipolar disorder.
  • Analysis of pharmaceutical industry developmental programs.
  • Discussion of future research directions.

Main Results:

  • Recent pharmacotherapeutic advances primarily improved tolerability and safety.
  • No new treatments have surpassed lithium's effectiveness.
  • Emerging treatments largely consist of modified anticonvulsants and atypical antipsychotics.

Conclusions:

  • Significant advancements in bipolar disorder treatment efficacy are lacking.
  • Future progress hinges on elucidating the disorder's causative pathogenetic molecular processes.
  • Understanding molecular mechanisms is crucial for developing more effective bipolar disorder therapies.